NCT00904579View on ClinicalTrials.gov

Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease

CompletedOBSERVATIONAL
Enrollment

19,929,901

Participants

Timeline

Start Date

July 1, 2006

Primary Completion Date

April 22, 2020

Study Completion Date

April 22, 2020

Conditions
Immunocompromised HostOrgan TransplantationCancer
Trial Locations (9)

12206

Colorado Cancer Registry, Denver

New York Cancer Registry, Albany

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

30303

Georgia Cancer Registry, Atlanta

52242

Iowa Cancer Registry, Iowa City

95811

California Cancer Registry, Sacramento

98109

Seattle Cancer Registry, Seattle

06134

Connecticut Cancer Registry, Hartford

08901

New Jersey Cancer Registry, New Brunswick

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00904579 - Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease | Biotech Hunter | Biotech Hunter